{"disease":{"id":"basal-cell-cancer","name":"basal cell cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06705608","title":"Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06661577","title":"An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University of Auckland, New Zealand","has_results":false},{"nct_id":"NCT03509467","title":"Using MC1R Genotype to Impact Melanoma Risk Behavior","phase":"NA","overall_status":"COMPLETED","enrollment_count":2054,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT03050268","title":"Familial Investigations of Childhood Cancer Predisposition","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT06598137","title":"Study to Examine Lesions of the Skin Using Confocal Laser Microscopy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":645,"lead_sponsor_name":"LMU Klinikum","has_results":false},{"nct_id":"NCT05853315","title":"BCC Excision Revisited","phase":"","overall_status":"COMPLETED","enrollment_count":451,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT06683846","title":"Ivonescimab in the Treatment of Multiple Advanced Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07361666","title":"Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji","has_results":false},{"nct_id":"NCT03233711","title":"Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":344,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00046189","title":"Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum","phase":"","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04842279","title":"FACE-Q in Facial Reconstructive Surgery: A Prospective Database","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT06227416","title":"Skin Tumor Biomarkers by Mass Spectrometry Imaging","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT04166318","title":"Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":252,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":false},{"nct_id":"NCT04444921","title":"EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":205,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06493786","title":"Identification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Association pour la Recherche Clinique et Immunologique","has_results":false},{"nct_id":"NCT05086692","title":"A Beta-only IL-2 ImmunoTherapY Study","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Medicenna Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06654999","title":"How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions.","phase":"","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Skin Analytics Limited","has_results":false},{"nct_id":"NCT06384053","title":"Skin Cancer and Hyperthermia and Radiotherapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Kantonsspital Winterthur KSW","has_results":false},{"nct_id":"NCT05188729","title":"Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Verrica Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT03422536","title":"Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"University of Arizona","has_results":true},{"nct_id":"NCT04916002","title":"A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":77,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT06894056","title":"Investigating the Effects of Orienting Skin Grafts Parallel to Skin Tension Lines on Quality of Life in Head and Neck Located Basal Cell Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Sifa Okulu - Independent Research Center of Dermatology and Venereology","has_results":false},{"nct_id":"NCT03734913","title":"A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":65,"lead_sponsor_name":"Guangdong Zhongsheng Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05859074","title":"A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03370861","title":"How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes","phase":"","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06398418","title":"R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":33,"lead_sponsor_name":"Rise Therapeutics LLC","has_results":false},{"nct_id":"NCT04470726","title":"Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"AiViva BioPharma, Inc.","has_results":false},{"nct_id":"NCT03534947","title":"A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Melanoma Institute Australia","has_results":false},{"nct_id":"NCT04552990","title":"Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT00470496","title":"Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":false},{"nct_id":"NCT07068568","title":"Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Federico II University","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}